期刊文献+

血清胱抑素C水平对血肌酐正常急性心肌梗死患者的预后价值探讨 被引量:3

Study on evaluating the prognostic value of the plasma cystatin C in patients with acute myocardial infarction and normal serum creatinine
原文传递
导出
摘要 目的评价血清胱抑素C(Cys-C)水平对急性心肌梗死(AMI)患者近期和远期预后的预测价值。方法选取血肌酐(Scr)正常(58~110μmol/L)的AMI住院患者174例,根据发病24h内血清Cys-C的中位数水平分为A组(Cys-C≤1.018mg/L)和B组(Cys-C>1.018mg/L)。记录住院及随访两年期间的心脏不良事件(MACE)发生情况。结果 (1)B组患者住院期间的心血管死亡及心力衰竭发生率(6.9%和25.3%)明显高于A组(1.1%和12.6%),差异有统计学意义(P<0.05);随访两年期间B组患者的心血管死亡及心力衰竭发生率(12.6%和23%)均明显高于A组(3.4%和10.3%),差异有统计学意义(P<0.05);两组住院期间均无再次AMI发生。随访期间再次AMI事件无统计学差异。(2)Logistic回归分析显示,血清Cys-C水平是MACE发生的独立危险因素(OR=1.038,P=0.01)。(3)ROC曲线分析,Cys-C预测MACE事件的敏感性及特异性高于肾功能指标Scr,其预测MACE临界值为0.996mg/L。结论心肌梗死急性期血清Cys-C水平可作为评价肾功能正常AMI患者预后的指标之一。 Objective To evaluate the short and long-term prognostic value of the plasma cystatin C(Cys-C)concentrations in patients with acute myocardial infarction and normal serum creatinine(Scr).Methods According to the changing of Cys-C median level within 24 hours of chest pain symptom onset,174 chosen patients with acute myocardial infarction and normal Scr(58-110 μmol/L)were classified into 2 groups:Group A(Cys-C≤1.018 mg/L)and Group B(Cys-C>1.018 mg/L).The cases of major adverse cardiac events(MACE)were recorded during in-hospital and the follow-up periods of two years.Results During in-hospital patients with cardiovascular death and heart failure in group B(6.9% and 25.3%)were significantly more than those in group A(1.1% and 12.6%),P<0.05;And in the follow-up period of two years,patients with cardiovascular death and heart failure in group B(12.6% and 23%)were also obviously more than patients in group A(3.4% and 10.3%),P<0.05.There was no significant difference about recurrent myocardial infarction during the follow-up period.Meanwhile,both groups had no recurrent myocardial infarction during in-hospital period.Logistic regression analysis showed that the Cys-C level was the independent risk factor for MACE(OR=1.038,P=0.001).On the basis of ROC curve analysis,Cys-C was stronger than kidney function index Scr in predicting the sensibility and specificity of cardiovascular events,and it calculated 0.996 mg/L as the cutoff level of MACE.Conclusions Cys-C concentrations may be one of criteria of evaluating prognostic value in patients with acute myocardial infarction and normal renal function.
出处 《中华临床医师杂志(电子版)》 CAS 2012年第24期8007-8011,共5页 Chinese Journal of Clinicians(Electronic Edition)
关键词 心肌梗死 抑素类 预后 Myocardial infarction Chalones Prognosis
  • 相关文献

参考文献16

  • 1黄君富,府伟灵.急性肾损伤早期实验诊断标志物[J].国际检验医学杂志,2010,31(5):462-464. 被引量:15
  • 2任爱英,王凡.血清胱抑素C的临床应用及研究[J].检验医学与临床,2008,5(1):32-34. 被引量:45
  • 3Shlipak M.G,Katz R,Fried L F,et al.Cystatin-C and mortality in elderly persons with heart failure. Journal of the American College of Cardiology . 2005
  • 4Blke E,Schieren G,Gripp S,et al.Cystatin C-a fast andreliable biomarker for glomerular filtration rate in head andneck cancer patients. Strahlenther Onkol . 2011
  • 5Derzhko R,Plaksej R,Przewlocka-Kosmala M,et al.Prediction of left ven-tricular dysfunction progression in patients with a first ST-elevation my ocardial infarction-contribution of cystatin C assessment. Coronary Artery Disease . 2009
  • 6Gao C,,Zhong L,Gao Y,et al.Cystatin C levels are associated with the prognosis of systolic heart failure patients. Arch Cardiovasc Dis . 2011
  • 7Rule AD,Bergstralh EJ,Slezak JM,et al.Glomerular filtration rate ??estimated by rystatin C among different elinical presentations. Kidney International . 2006
  • 8Sarnak MJ,Kate R,Stehman-Breen CO, et al.Cystatin C concentration as a risk factor for heart failure in older adults. Annals of Internal Medicine . 2005
  • 9Moran A,Katz R,Smith NL,et al.Cystatin Concentrationas a predictor of systolic and diastolic heart failure. JCard Fail . 2008
  • 10Eiji I,Kigen J,Yoshio K,et al.Prognostic significance of cystatin C in patients with ST-elevation myocardial infarction. Circulation . 2009

二级参考文献21

  • 1[1]Anderson JK,Schmidt C,Nordin G,et al.determined by a rapid,automated particle-enhanced turbidi metric method,is a batter marker than serum creatinine for glomerular filtration rate[J].Clin Chem,1994,40(10):1921-1926.
  • 2[2]Finney H,Newman DJ,Gruber W.Initial evaluation of cystatin c measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems(BNA,BN11)[J].Clin Chem,1997,43(6):1016-1020.
  • 3[3]Randers E,Erlanden EJ.Serum Cystatin C as an endogenous marker of the renal function ; a review[J].Clin Chem Labmed,1999,37(4):389-395.
  • 4[5]Pergande M,Jung K.Sandwich enzy me immunoassay of Cystatin C in serum with commercially available antibodies[J].Chin Chem,1993,39(9):1885-1990.
  • 5[6]Randers E,Erlandsen EJ,Pederson QL.Serum Cystatin C as an endogenous parameter of renal function in patients with normal to moderately impaired kidney function[J].Chin Nephrol,2000,54(3):203-209.
  • 6AH T,Khan I,Simpson W,et al.Incidence and outcomes in acute kidney injury:a comprehensive population based study[J].J Am Soc Nephrol,2007,18:1292-1298.
  • 7Andrew JPL,Ahmed Sayed.Acute kidney injury:how do we define it?[J].Ann Clin Biochem,2010,47:4-7.
  • 8Mai TN,Prasad D.Biomarkers for the early detection of acute kidney injury[J].Pediatr Nephrol,2008,23:2151-2157.
  • 9Mori K,Lee HT,Rapoport D,et al.Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury[J].J Clin Invest,2005,115:610-621.
  • 10Schmitt-Ott KM,Mori K,Kalandadze A,et al.Neutro-phil gelatinaseassociated lipocalin-mediated iron traffic in kidney epithelia[J].Curr Opin Nephrol Hypertens,2005,15:442-449.

共引文献58

同被引文献37

  • 1Tidman M, Sjostrom P, Jones I. A comparison of GFR estimating formulae based upon s-cystatin C and s- creatinine and a combination of the two [J], Nephrol Dial Transplant, 2008, 23 (1): 154-160.
  • 2Delanaye P, Cavalier E, Morel J, et al. Detection of decreased glomerular filtration rate in intensive care units: serum cystatin C versus serum creatinine [J]. BMC Nephrol, 2014, 15: 9.
  • 3Uchino S, Bellomo R, Morimatsu H, et al. Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for thekidney (B.E.S.T. kidney) investigators[J]. Intensive Care Med, 2007, 33 (9): 1563-1570.
  • 4Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012[J]. Crit Care Med, 2013, 41 (2): 580-637.
  • 5Hock FJ, Kemperman FA, Krediet RT. A comparison between cystafin C, plasma ereatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate [J]. Nephrol Dial Transplant, 2003, 18 (10): 2024-2031.
  • 6Cockeroft DW, Gault MH. Prediction of creatinine cle- arance from serum creatinine [J]. Nephron, 1976, 16 (1): 31-41.
  • 7Dickinson DP, Zhao Y, Thiesse M, et al. Direct ma- pping of seven genes encoding human type 2 cystatins to a single site located 20p11.2 [J]. Genomics, 1994, 24 (1): 172-175.
  • 8Rule AD, Bergstralh E J, Slezak JM, et al. Glomerular filtration rate estimated by cystatin C among different clinical presentations [J]. Kidney Int, 2006, 69 (2): 399-405.
  • 9Zhang Z, Lu B, Sheng X, et al. Cystatin C in Pre- diction of Acute Kidney Injury: A Systemic Review and Meta-analysis[J]. Am J Kidney Dis, 2011, 58 (3): 356-365.
  • 10Nejat M, Picketing JW, Walker R J, et al. Urinary cy- statin C is diagnostic of acute kidney injury and sepsis, and predicts mortality in the intensive care unite [J]. Ctit Care, 2010, 14 (3): R85.

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部